Cite
HARVARD Citation
Spriano, F. et al. (n.d.). The first-in-class WASP activator EG-011 is active in lymphoma and multiple myeloma cell lines resistant to FDA approved compounds. European journal of cancer. pp. S107-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Spriano, F. et al. (n.d.). The first-in-class WASP activator EG-011 is active in lymphoma and multiple myeloma cell lines resistant to FDA approved compounds. European journal of cancer. pp. S107-. [Online].